Content TV

+

Decision Making in HF: How and when should I treat? Part II Tricuspid

AV VALVES Summit 2023 Decision Making in HF:How & when should I treat? Part II Tricuspid

Importance of decision making in treating AV valve disease – how and when to intervene? Tricuspid case presented by Erwan Donal.

Learn More:

AV VALVE SUMMIT 2023

TRENDING TOPICS

Mastering TAVI implantation: procedural tricks with Navitor across all valve sizes

Procedural tip & tricks with Navitor across all valve sizes

Mastering TAVI implantation: procedural tricks with Navitor across all valve sizes

What are the learnings from the one-year VANTAGE TAVI outcomes in low/intermediate-risk patients?

1-year VANTAGE TAVI outcomes in low/intermediate-risk patients

What are the learnings from the one-year VANTAGE TAVI outcomes in low/intermediate-risk patients?

Transcatheter Aortic Valves Implant

Advancing TAVI Practice with Navitor™

The content on this website is intended for healthcare professionals in EMEA with applicable health authority product registrations, excepted those practicing in France as some of the content is not in compliance with the French Advertising law N°2011-2012 dated 29th December 2011 article 34. Click OK to confirm you are a healthcare professional to proceed.

OK Decline

AV VALVES Summit 2023 Decision Making in HF:How & when should I treat? Part II Tricuspid

Related Videos

TRENDING TOPICS

Procedural tip & tricks with Navitor across all valve sizes

1-year VANTAGE TAVI outcomes in low/intermediate-risk patients

Transcatheter Aortic Valves Implant

CONNEXT

Valvular Heart Disease Guidelines at a Glance

Demonstrated Outcomes. Life-Changing Intervention

Reduced HF Hospitalisation. Improved Quality of Life

Immediate Relief. Durable Benefits

CONNEXT

M-TEER: Best treatment strategies for FMR AND DMR

M-TEER: State of the art echocardiography imaging modalities

AV VALVES Summit 2026 | Introduction

New clinical evidence and patient selection M-TEER therapy